Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07637851 |
| Title | Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer (RegeNovar) |
| Acronym | RegeNovar |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ARCAGY/ GINECO GROUP |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA |